INSIGHTS ON DRUG DEVELOPMENT
-
Optimization And Scale-Up Of A Plasmid DNA Production Process
Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.
-
Advanced Process Development And Manufacturing Solutions
Scaling complex chemical processes requires early risk identification, integrated safety and analytical expertise, and efficient tech transfer.
-
Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience
Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients7/23/2025
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
CRISPR Meets LNPs: A New Era In Cell And Gene Therapies7/8/2025
Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
Addressing Raw Material Handling Challenges By Dry Granulation8/12/2025
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Using Residual DNA Quantification Data To De-Risk mAb Development6/11/2026
Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.
-
How To Capture Growth In The Expanding Metabolic Drug Market12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
DRUG DEVELOPMENT SOLUTIONS
-
Enhance your workflow with the Avanti JXN-26 high-speed Centrifuge System
- 6.0 L Max Capacity
- 26,000 RPM
- 81,770 x g
-
Dissection Perfection
Laser Microdissection (LMD, also known as Laser Capture Microdissection or LCM) enables users to isolate specific single cells or entire areas of tissue. Powered by a unique laser design and dynamic software, Leica LMD systems allow users to easily isolate Regions of Interest (ROI) from entire areas of tissue down to single cells or even subcellular structures such as chromosomes.
-
Encoded stereo microscopes Leica M165 C - Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
-
Coded microscopes consistently deliver calibrated and comparable images
-
Reproduce images in moments with the Leica “Store and Recall” function
-
Fully apochromatic corrected zoom optics deliver high quality images
-
Customize the microscope system to your task with the exclusive range of accessories
-
-
Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.
-
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.